EU underfunds medicines while allocating billions to arms
The EU is mobilizing up to €850 billion for so-called defense and armament, missing out on building true security through investment into health
Is Big Pharma’s pollution deregulation campaign fueling the next pandemic?
Big Pharma keeps pushing for weaker pollution standards despite proven risks to human and environmental health
Public Pharma: still a missing debate in mainstream academia
Despite drug shortages and soaring prices, mainstream academia continues to ignore Public Pharma as a solution
WHO Executive Board to discuss substandard medical products: what is it all about?
The WHO Executive Board will discuss global health priorities this week, including substandard and falsified medical products, with key implications for public pharmaceutical initiatives
Patent law changes in Indonesia may hinder access to life-changing medicines
Indonesia’s new patent law has raised alarm over potential barriers to accessing life-saving medicines
London activists push Gilead to lower price of new HIV drug
Protesters condemn Gilead for prioritizing exorbitant profits over public health, accusing the pharmaceutical company of obstructing widespread generic production of new HIV drug lenacapavir
El extraño caso de la persecución a Daniel Jadue
Daniel Jadue, miembro del Partido Comunista de Chile y ex alcalde de Recoleta, fue liberado tras permanecer 91 días en prisión preventiva.
Public Pharma vs. abusive prices: the case of the latest HIV-prevention drug
The high price tag on the HIV drug lenacapavir underscores the widespread dysfunction within Big Pharma
The strange case of the persecution of Daniel Jadue
Daniel Jadue, a member of the Communist Party of Chile and the former mayor of Recoleta, was released after being held in preventative detention for 91 days
Colombia to make HIV treatment more accessible through compulsory licensing
The Colombian government recently issued a compulsory license for HIV drug dolutegravir, making the treatment more accessible for thousands of people
India’s newly amended patent rules threaten affordable medicines in the Global South
New amendments to patent rules in India will jeopardize the country’s ability to produce generics, dealing a strong blow to access to medicines in both India and other countries of the Global South
Public pharma infrastructure could give the world access to a treasure trove of medicines
Health activists and scientists in Europe met to develop strategies to build regional public pharmaceutical infrastructure as pandemic lessons seems lost on governments and producers
- The People’s Forum condemns right-wing attempts to silence dissent and solidarity with Palestine
- Palestine solidarity protests in Morocco delay Maersk ship
- With mass protests across the country, movement against Trump’s agenda grows
- Children in Gaza charred to death as Israel strikes displaced people’s tents in designated “safe zone”
- Farmers in Pakistan mobilize to demand fair prices and agrarian reform
